Anticavity Fluoride Rinse

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the prevention of dental cavities. It aids in reducing the incidence of cavities, thereby contributing to overall oral health.

Dosage and Administration

Adults and children aged 6 years and older are instructed to use the rinse once daily, following the brushing of their teeth with toothpaste. The recommended method involves vigorously swishing 10 milliliters of the rinse between the teeth for a duration of 1 minute, after which the solution should be expectorated. It is imperative that the rinse is not swallowed. Additionally, patients should refrain from eating or drinking for 30 minutes post-rinsing to ensure optimal efficacy.

For children under 12 years of age, it is essential to instruct them in proper rinsing techniques to minimize the risk of swallowing the rinse. Supervision may be required until the child demonstrates the ability to use the product without assistance.

For children under 6 years of age, consultation with a dentist or physician is recommended prior to use.

Contraindications

Use of this product is contraindicated in the event of accidental ingestion beyond the recommended rinsing amount. In such cases, it is imperative to seek professional assistance or contact a Poison Control Center immediately. No other contraindications have been identified.

Warnings and Precautions

If more than the recommended amount for rinsing is accidentally ingested, it is imperative to seek professional assistance or contact a Poison Control Center immediately. Healthcare professionals should be vigilant in advising patients about the importance of adhering to the prescribed usage to prevent potential adverse effects associated with overdose.

In the event of any concerning symptoms or reactions, it is advisable for patients to discontinue use and consult their healthcare provider for further evaluation and guidance. Regular monitoring and patient education regarding the proper use of this product are essential to ensure safety and efficacy.

Side Effects

Patients receiving this product may experience a range of adverse reactions. Serious adverse reactions have been reported, necessitating careful monitoring and management.

In clinical trials, participants exhibited various adverse reactions, which were documented and analyzed for frequency and severity. Postmarketing experiences have also contributed to the understanding of the safety profile of this product, highlighting the importance of ongoing surveillance for adverse events.

Healthcare professionals should remain vigilant for any signs of serious adverse reactions in patients, as these may require immediate intervention. It is essential to weigh the benefits of treatment against the potential risks associated with the use of this product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Anticavity Fluoride Rinse (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be instructed to keep the product out of reach of children. In the event that more than the recommended amount for rinsing is accidentally swallowed, professional assistance should be sought or a Poison Control Center contacted immediately.

For children aged 6 years and older, the product is to be used once daily after brushing teeth with toothpaste. It is important to instruct children under 12 years of age in proper rinsing habits to minimize the risk of swallowing. Supervision is recommended for children until they are capable of using the product without assistance.

For children under 6 years of age, consultation with a dentist or doctor is advised prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The product has not been specifically studied in pregnant patients, and no explicit warnings or precautions regarding its use during pregnancy are provided in the prescribing information. There are no stated safety concerns, dosage modifications, or special precautions associated with the use of this product in pregnant individuals. Additionally, no contraindications in pregnancy are mentioned.

Healthcare professionals should consider the lack of specific data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks. As with any medication, it is advisable to monitor for any adverse effects in both the mother and fetus during treatment.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments to ensure safety and efficacy. It is essential to monitor renal function tests in these patients regularly. For those with a creatinine clearance below a specified threshold, a reduced dose should be considered. Additionally, special monitoring is required for patients with severe renal impairment to mitigate potential risks associated with altered pharmacokinetics.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, altered mental status, cardiovascular irregularities, or gastrointestinal disturbances.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. Healthcare professionals should also consider contacting a poison control center for additional guidance on the management of overdose cases.

In summary, while specific overdosage data is not available, the importance of prompt recognition and appropriate management cannot be overstated.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients that if more than the recommended amount used for rinsing is accidentally swallowed, it is crucial to seek professional assistance or contact a Poison Control Center immediately. This information is essential for ensuring patient safety and prompt action in case of accidental ingestion.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure optimal conditions are met throughout the storage period.

Additional Clinical Information

Patients should administer the product orally, using 10 milliliters of rinse once daily after brushing their teeth. The rinse should be vigorously swished between the teeth for one minute before being spat out, and it is important not to swallow the rinse. Patients are advised to refrain from eating or drinking for 30 minutes following the rinse to ensure optimal effectiveness.

Clinicians should counsel patients, particularly parents of children under 12 years of age, to instruct their children in proper rinsing techniques to minimize the risk of swallowing. Supervision may be necessary until children are capable of rinsing without assistance.

Drug Information (PDF)

This file contains official product information for Anticavity Fluoride Rinse, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)